Sit Investment Associates’s Regeneron Pharmaceuticals REGN Stock Holding History

Sit Investment Associates’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-5,040	Closed	-$2.57M	–	523
2015 Q2	$2.57M	Sell	5,040 -100	-2%	-$48.8K	0.05%	218
2015 Q1	$2.32M	Sell	5,140 -2,900	-36%	-$1.23M	0.04%	231
2014 Q4	$3.3M	Sell	8,040 -300	-4%	-$118K	0.05%	225
2014 Q3	$3.01M	Sell	8,340 -100	-1%	-$33.5K	0.05%	229
2014 Q2	$2.38M	Sell	8,440 -10	-0.1%	-$2.96K	0.04%	280
2014 Q1	$2.54M	Sell	8,450 -1,250	-13%	-$385K	0.04%	266
2013 Q4	$2.67M	Buy	+9,700	New	+$2.79M	0.05%	258

Other funds holding REGN

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Sit Investment Associates's REGN Position: Q3 2015 in Review

Sit Investment Associates sold out of Regeneron Pharmaceuticals (REGN) in Q3 2015, closing a stake of 5,040 shares — an estimated $2.57M sold.

Sit Investment Associates first reported a position in REGN in Q4 2013 and held it in 7 quarters. The position peaked at $3.3M in Q4 2014. 563 funds tracked by Wall St. Rank hold REGN as of Q3 2015.

Sit Investment Associates reported no remaining Regeneron Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
Sit Investment Associates sold 5,040 Regeneron Pharmaceuticals shares in Q3 2015, an estimated $2.57M.
Sit Investment Associates first reported a position in Regeneron Pharmaceuticals in Q4 2013 and held it in 7 quarters.
Sit Investment Associates's Regeneron Pharmaceuticals position peaked at $3.3M in Q4 2014.
563 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2015.

Based on Sit Investment Associates's 13F filing for Q3 2015, filed 4 Nov 2015.